ArticleEMBO reports2026
A Nanos3-containing protein complex can activate RNA translation in primordial germ cells in vivo.
Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Maintaining the germline fate requires tight post-transcriptional control of RNA function. Here, we investigate how primordial germ cell (PGC) identity is maintained in zebrafish and reveal that the conserved RNA-binding proteins Nanos3 and Dead End1 form a complex that safeguards PGC identity. Using transcriptomics and in vivo imaging-based analyses, we show that this complex controls the translational activation and localization of both nanos3 and dead end1 RNAs, establishing a positive feedback loop crucial for regulating their protein expression. These findings uncover a previously unknown layer of control over germline development, where a complex containing Nanos3, a protein associated with the inhibition of RNA translation, acts as an activator by interacting with an eIF3 complex protein to promote translation, thereby maintaining specific RNAs at the periphery of phase-separated germ cell granules. Disrupting the physical interaction between Nanos3 and Dead End1 leads to transdifferentiation of germ cells into somatic lineages. Overall, our findings identify a self-sustaining mechanism of translational activation in vivo, positioning the Nanos3-Dead End1 complex as a central effector of germline fate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.